TransCode Therapeutics, Inc. Announces Closing of Public Offering
24 juil. 2024 16h05 HE
|
TransCode Therapeutics, Inc.
Boston, MA — July 24, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors
24 juil. 2024 11h15 HE
|
NeOnc Technologies Holdings, Inc.
NEO212™ completes initial two cohorts of Phase 1 study under FDA Investigative New Drug (IND).Study tests the safety of NeOnc’s patented novel drug, NEO212™, which is the bioconjugation of its leading...
Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024
23 juil. 2024 16h05 HE
|
Lumos Pharma, Inc.
AUSTIN, Texas, July 23, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report second...
Global Forensic Technologies and Services Market Insights, 2024-2030 - Rise in Gun Violence Driving Demand for Forensic Ballistics
23 juil. 2024 12h46 HE
|
Research and Markets
Dublin, July 23, 2024 (GLOBE NEWSWIRE) -- The "Forensic Technologies and Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
TransCode Therapeutics, Inc. Announces Pricing of Public Offering
22 juil. 2024 22h30 HE
|
TransCode Therapeutics, Inc.
Boston, MA — July 22, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed t
TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
22 juil. 2024 16h07 HE
|
TransCode Therapeutics, Inc.
Boston, MA – July 22, 2024 – TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed t
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18 juil. 2024 16h13 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...
Gel Electrophoresis Market Insights Report, 2024-2030 - A Projected $2.5 Billion Global Market with Laboratory Research End-users Accounting for $1.2 Billion
18 juil. 2024 11h42 HE
|
Research and Markets
Dublin, July 18, 2024 (GLOBE NEWSWIRE) -- The "Gel Electrophoresis - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gel...
Tissue Engineering Market Size is Expected to Reach USD 12.43 Billion by 2032, Growing at a CAGR of 14.40%: Straits Research
18 juil. 2024 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, July 18, 2024 (GLOBE NEWSWIRE) -- As per the Latest Report by Straits Research, the global tissue engineering market size was valued at USD 4,333.61 million in 2023. It is...
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA® (omadacycline) for Patients with Moderate to Severe Community-Acquired Bacterial Pneumonia
18 juil. 2024 07h30 HE
|
Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals Announces Positive Top-line Efficacy and Safety Data from Post-Marketing Study of NUZYRA®